Back

The value of Cystatin C and NT-proBNP in the diagnosis of type 1 cardiorenal syndrome

23 June 2023 (08:30 - 17:45)
Organised by: Logo
Congress Presentation Part of: Poster session 1 Treatment ACNAP Premium Access ACNAP Congress 2023 Association of Cardiovascular Nursing and Allied Professions (ACNAP)

About the speaker

Photo
Doctor Thai Hao Phan

University of Medicine Pham Ngoc Thach, Ho Chi Minh (Viet Nam)

35 More presentations in this session

Presentation thumbnail
Co-design of an atrial fibrillation mHealth intervention to increase medication adherence
Miss A. Pearsons (Edinburgh, GB)
Abstract
Presentation thumbnail
Exploring patients' needs and perceptions regarding a specialised lifestyle oriented atrial fibrillation outpatient clinic: a qualitative study
Ms B. De Louw (Eindhoven, NL)
Abstract Slides
Presentation thumbnail
Epicardial adiposity in people with atrial fibrillation modified by physical exercise: an umbrella review
Professor C. Breen (Edinburgh, GB)
Abstract Slides
Presentation thumbnail
Pulmonary vein isolation with a novel radiofrequency balloon catheter: real-world predictors of single shot isolation
Presentation thumbnail
The impact of the frailty syndrome on the functioning of patients with atrial fibrillation.
Assistant Professor B. Banaszak-Zak (Katowice, PL)
Abstract Slides

Access the full session

Session thumbnail
Poster session 1

The Event

Event poster

ACNAP Congress 2023

23 June 2023 08:30 CET
You may be interested in
thumbnail
Congress Presentation
The value of Cystatin C in the diagnosis of cardiorenal syndrome type 1
29 June 2021
thumbnail
Congress Presentation
N-terminal pro-B-type natriuretic peptide concentrations, testing and associations with outcomes: an analysis of the Swedish Heart Failure Registry and the Stockholm CREAtinine Measurements Cohorts
20 May 2023
thumbnail
Congress Presentation
Biomarkers for monitoring patients with cardiac amyloidosis during transthyretin-stabilizer therapy
31 August 2024
thumbnail
Congress Presentation
Echographic predictive factors of worsening outcome in type 1 cardiorenal syndrome
11 May 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources